PROCEPT BioRobotics Corp financial data

Symbol
PRCT on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
150 Baytech Drive, San Jose, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 2, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 790 % -18.7%
Quick Ratio 103 % +12.8%
Debt-to-equity 48.1 % +0.19%
Return On Equity -41.4 % +12.8%
Return On Assets -27.9 % +12.9%
Operating Margin -69.4 % +36.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 51.4 M shares +14.2%
Common Stock, Shares, Outstanding 51.4 M shares +14.2%
Entity Public Float 1.4 B USD +40%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 51 M shares +13.2%
Weighted Average Number of Shares Outstanding, Diluted 51 M shares +13.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 156 M USD +83.4%
Cost of Revenue 72.7 M USD +67.8%
Research and Development Expense 50.8 M USD +46.3%
Operating Income (Loss) -108 M USD -16.1%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -103 M USD -4.99%
Earnings Per Share, Basic -2.12 USD/shares +3.64%
Earnings Per Share, Diluted -2.12 USD/shares +3.64%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 226 M USD +24.6%
Accounts Receivable, after Allowance for Credit Loss, Current 56.1 M USD +172%
Inventory, Net 41.6 M USD +6.93%
Assets, Current 329 M USD +34%
Property, Plant and Equipment, Net 28.5 M USD +139%
Operating Lease, Right-of-Use Asset 19.9 M USD -11.4%
Other Assets, Noncurrent 1.16 M USD +2175%
Assets 383 M USD +34.6%
Accounts Payable, Current 10.1 M USD -2.49%
Contract with Customer, Liability, Current 5.86 M USD +48.6%
Liabilities, Current 38.7 M USD +18.9%
Contract with Customer, Liability, Noncurrent 517 K USD
Operating Lease, Liability, Noncurrent 28.3 M USD +9.83%
Other Liabilities, Noncurrent 517 K USD
Liabilities 119 M USD +6.76%
Accumulated Other Comprehensive Income (Loss), Net of Tax 113 K USD +653%
Retained Earnings (Accumulated Deficit) -481 M USD -27.4%
Stockholders' Equity Attributable to Parent 264 M USD +52.5%
Liabilities and Equity 383 M USD +34.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -32.3 M USD +10.1%
Net Cash Provided by (Used in) Financing Activities 2.59 M USD +581%
Net Cash Provided by (Used in) Investing Activities -1.95 M USD +63.6%
Common Stock, Shares Authorized 300 M shares 0%
Common Stock, Shares, Issued 51.4 M shares +14.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -31.6 M USD +22.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 229 M USD +23.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1 M USD -10.4%
Deferred Tax Assets, Valuation Allowance 121 M USD +29.1%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 126 M USD +26.6%
Operating Lease, Liability 30 M USD +4.3%
Payments to Acquire Property, Plant, and Equipment 1.95 M USD -63.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -103 M USD -4.97%
Lessee, Operating Lease, Liability, to be Paid 43.9 M USD -11.4%
Property, Plant and Equipment, Gross 33.3 M USD +53.8%
Operating Lease, Liability, Current 1.7 M USD -43.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.43 M USD +3%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.3 M USD +2.73%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 13.9 M USD -33.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.81 M USD +8.63%
Deferred Tax Assets, Operating Loss Carryforwards 80.3 M USD +23.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10 M shares 0%
Unrecognized Tax Benefits 3.39 M USD +25.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.95 M USD +3%
Additional Paid in Capital 744 M USD +35.3%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 300 K USD 0%
Depreciation, Depletion and Amortization 1.18 M USD +49.3%
Deferred Tax Assets, Net of Valuation Allowance 4.96 M USD -14.9%
Share-based Payment Arrangement, Expense 21.7 M USD +73.2%
Interest Expense 4.15 M USD -10.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%